Alltrna
Engineered tRNA medicines for patients with genetic diseases caused by disrupted protein production
Highlights
- New on EvolcAdded 2026-11-14
About Alltrna
Alltrna develops engineered, chemically modified tRNA oligonucleotides intended to restore protein production in genetic diseases. Its platform uses machine-learning tools to design tRNA molecules with desired pharmacologic properties.
The company is developing treatments for premature termination, or stop, codon mutations and other genetic diseases. Its open positions are based in Cambridge, Massachusetts.
Flagship Pioneering launched Alltrna in 2021. The company announced a $109 million Series B financing in 2023 and approval to initiate a first-in-human clinical trial in 2026.
Product: A platform for designing engineered tRNA oligonucleotide therapeutics to restore protein production in genetic diseases.
Jobs at Alltrna
More biotech & pharma companies
Allucent
Clinical research, drug development and regulatory services for small and mid-sized biotech and biopharma companiesRemote-friendlyAltos Labs
Biotech developing cell rejuvenation medicines to reverse disease, with sites in San Francisco Bay Area, San Diego and Cambridge, UKSalary transparentAlumis
Biopharma developing late-stage targeted therapies for immune-mediated diseases such as psoriasisNew on EvolcAmgen
Biotechnology medicines for patients with serious diseases, developed and supplied to healthcare markets worldwideAmylyx Pharmaceuticals
Develops investigational therapies for people with rare and serious diseasesAmyris
Precision-fermentation and biomanufacturing services for companies developing renewable chemicals and ingredientsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
